Potential Molecular Biomarkers of Central Nervous System Damage in Breast Cancer Survivors

Damage of the central nervous system (CNS), manifested by cognitive impairment, occurs in 80% of women with breast cancer (BC) as a complication of surgical treatment and radiochemotherapy. In this study, the levels of ICAM-1, PECAM-1, NSE, and anti-NR-2 antibodies which are associated with the dama...

Descripción completa

Detalles Bibliográficos
Autores principales: Pospelova, Maria, Krasnikova, Varvara, Fionik, Olga, Alekseeva, Tatyana, Samochernykh, Konstantin, Ivanova, Nataliya, Trofimov, Nikita, Vavilova, Tatyana, Vasilieva, Elena, Topuzova, Maria, Chaykovskaya, Alexandra, Makhanova, Albina, Mikhalicheva, Anna, Bukkieva, Tatyana, Restor, Kenneth, Combs, Stephanie, Shevtsov, Maxim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911416/
https://www.ncbi.nlm.nih.gov/pubmed/35268306
http://dx.doi.org/10.3390/jcm11051215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911416/
https://www.ncbi.nlm.nih.gov/pubmed/35268306
http://dx.doi.org/10.3390/jcm11051215

Ejemplares similares